Elixinol Wellness Limited
ELLXF
$0.01
$0.0092.50%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.54M | -2.41M | -1.28M | -1.19M | -1.13M |
| Total Depreciation and Amortization | 558.60K | 605.60K | 657.70K | 670.90K | 687.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 408.90K | 657.80K | 908.10K | 548.50K | 196.70K |
| Change in Net Operating Assets | 494.10K | -759.10K | -2.04M | -2.04M | -2.04M |
| Cash from Operations | -2.08M | -1.91M | -1.75M | -2.02M | -2.29M |
| Capital Expenditure | -42.40K | -30.20K | -18.20K | -28.80K | -39.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -76.70K | -191.80K | -311.30K | -904.40K | -1.50M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -21.90K | -16.30K | -10.70K | 741.00K | 1.49M |
| Cash from Investing | -140.80K | -238.10K | -340.10K | -192.10K | -44.60K |
| Total Debt Issued | 1.61M | 1.93M | 2.26M | 1.56M | 861.00K |
| Total Debt Repaid | -305.00K | -634.50K | -964.00K | -1.00M | -1.04M |
| Issuance of Common Stock | 2.69M | 2.17M | 1.65M | 3.15M | 4.66M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -339.00K | -260.00K | -181.00K | -372.50K | -564.00K |
| Cash from Financing | 2.36M | 2.07M | 1.78M | 2.18M | 2.58M |
| Foreign Exchange rate Adjustments | 70.50K | 26.80K | -16.70K | -11.60K | -6.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 214.10K | -52.90K | -324.10K | -40.70K | 242.20K |